Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer

被引:0
作者
Wang, Biyun [1 ]
Li, Yumeng [1 ]
Zhao, Yannan [1 ]
Sang, Die [2 ]
Yuan, Peng [3 ]
Zhao, Yanxia [4 ]
Lv, Zheng [4 ]
Xie, Ning [5 ]
Li, Nanling [6 ]
Li, Juanjuan [7 ]
Wang, Fang [8 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Beijing Zhongke Sanhuan Hitech Co Ltd, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Tumor Hosp, Beijing, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[5] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[6] Xijing Hosp, Xian, Peoples R China
[7] Wuhan Univ, Renmin Hosp, Wuhan, Peoples R China
[8] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词
breast cancer; real-world effectiveness; trastuzumab deruxtecan; systemic therapy;
D O I
10.1016/j.lanwpc.2024.101416
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
[21]   Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy [J].
Leticia Varella ;
Akaolisa Samuel Eziokwu ;
Xuefei Jia ;
Megan Kruse ;
Halle C. F. Moore ;
George Thomas Budd ;
Jame Abraham ;
Alberto J. Montero .
Breast Cancer Research and Treatment, 2019, 176 :429-434
[22]   Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer [J].
Rugo, Hope S. ;
Liu, Xianchen ;
Li, Benjamin ;
McRoy, Lynn ;
Chen, Connie ;
Layman, Rachel M. ;
Brufsky, Adam .
ONCOLOGIST, 2023, 28 (10) :866-874
[23]   Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy [J].
Varella, Leticia ;
Eziokwu, Akaolisa Samuel ;
Jia, Xuefei ;
Kruse, Megan ;
Moore, Halle C. F. ;
Budd, George Thomas ;
Abraham, Jame ;
Montero, Alberto J. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) :429-434
[24]   Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2-metastatic breast cancer [J].
Cuyun Carter, Gebra ;
Sheffield, Kristin M. ;
Gossai, Anala ;
Huang, Yu-Jing ;
Zhu, Yajun Emily ;
Bowman, Lee ;
Nash Smyth, Emily ;
Mathur, Raina ;
Cohen, Aaron B. ;
Rasmussen, Erik ;
Balakrishna, Shreya ;
Morato Guimaraes, Claudia ;
Rybowski, Sarah ;
Seidman, Andrew D. .
CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) :1179-1187
[25]   Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer [J].
Guarneri, Valentina ;
Coelho, Jose Luis Passos ;
Duhoux, Francois P. ;
Egle, Daniel ;
Garcia-Saenz, Jose angel ;
Penault-Llorca, Frederique ;
Selander, Katri ;
Wildiers, Hans ;
Zaman, Khalil ;
Laeis, Petra ;
Lucerna, Markus ;
Pierga, Jean-Yves .
FUTURE ONCOLOGY, 2024, 20 (18) :1237-1250
[26]   Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis [J].
Liang, Xu ;
Zhang, Linhui ;
Gui, Xinyu ;
Di, Lijun ;
Li, Huiping ;
Song, Guohong .
CANCER, 2024, 130 :1476-1487
[27]   Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients [J].
Takada, Shinya ;
Maeda, Hideki ;
Umehara, Kengo ;
Kuwahara, Sayuri ;
Yamamoto, Mitsugu ;
Tomioka, Nobumoto ;
Watanabe, Kenichi ;
Mino, Kozo .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (08) :1105-1111
[28]   Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis [J].
Feinberg, Bruce ;
Kish, Jonathan ;
Dokubo, Igoni ;
Wojtnek, Jeff ;
Gajra, Ajeet ;
Lard, Kevin .
ONCOLOGIST, 2020, 25 (04) :319-326
[29]   Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study [J].
Tai, Yi-Jou ;
Lee, Chung-Chen ;
Chen, Yong-Chen ;
You, San-Lin ;
Chiang, Ying-Cheng .
GYNECOLOGIC ONCOLOGY REPORTS, 2025, 59
[30]   Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study [J].
Sang, Die ;
Su, Yanfang ;
Zhang, Yurong ;
Guan, Yanfeng ;
Fan, Shanmin ;
Zhang, Jintao ;
Zheng, Lijun ;
Wang, Yanling ;
Guo, Ying ;
Lei, Zixuan ;
Li, Man ;
Yuan, Peng .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17